富蘭克林坦伯頓全球投資系列-生技領航基金A(acc)股
32.86美元0.21(0.64%)
2023/09/21更新
績效 / 1月0.87%
3月3.59%
1年6.44%
晨星評等 - 1.現金2.67%
- 2.股票11.66%
- 3.債券0.00%
- 4.其他85.67%
- 1.美國84.61%
- 2.英國4.83%
- 3.新興亞洲3.79%
- 4.歐元區1.84%
- 5.歐洲不包含歐元區0.94%
- 1.Amgen Inc7.28%
- 2.Vertex Pharmaceuticals Inc7.07%
- 3.Regeneron Pharmaceuticals Inc6.99%
- 4.Biogen Inc5.12%
- 5.Gilead Sciences Inc4.38%
- 6.Jazz Pharmaceuticals PLC4.15%
- 7.argenx SE ADR4.07%
- 8.AstraZeneca PLC ADR3.82%
- 9.Ascendis Pharma A/S ADR3.79%
- 10.PTC Therapeutics Inc3.16%
- 1.現金2.67%
- 2.股票11.66%
- 3.債券0.00%
- 4.其他85.67%
- 1.美國84.61%
- 2.英國4.83%
- 3.新興亞洲3.79%
- 4.歐元區1.84%
- 5.歐洲不包含歐元區0.94%
- 1.Amgen Inc7.28%
- 2.Vertex Pharmaceuticals Inc7.07%
- 3.Regeneron Pharmaceuticals Inc6.99%
- 4.Biogen Inc5.12%
- 5.Gilead Sciences Inc4.38%
- 6.Jazz Pharmaceuticals PLC4.15%
- 7.argenx SE ADR4.07%
- 8.AstraZeneca PLC ADR3.82%
- 9.Ascendis Pharma A/S ADR3.79%
- 10.PTC Therapeutics Inc3.16%